Alkem Laboratories has become the first Indian drugmaker to diversify into medical devices after partnering with US-based Exactech to manufacture and market Exactech's joint replacement implants in India. Exactech will provide Alkem MedTech access to its designs, technology, and marketing rights. The endeavor is expected to commercialize in 1-2 years, targeting India's growing orthopaedic market.
